Aarkstore.com announces, The Latest market research report is available inits vast collection:Equine Encephalitis – Pipeline Review, H2 2012RSS link of Global Markets DirectSummaryGlobal Markets Direct’s, Equine Encephalitis - Pipeline Review, H2 2012, providesan overview of the Equine Encephalitis therapeutic pipeline. This report providesinformation on the therapeutic development for Equine Encephalitis, complete withlatest updates, and special features on late-stage and discontinued projects. It alsoreviews key players involved in the therapeutic development for EquineEncephalitis. Equine Encephalitis - Pipeline Review, H2 2012 is built using data andinformation sourced from Global Markets Direct’s proprietary databases,Company/University websites, SEC filings, investor presentations and featuredpress releases from company/university sites and industry-specific third partysources, put together by Global Markets Direct’s team.Note*: Certain sections in the report may be removed or altered based on theavailability and relevance of data for the indicated disease.Scope- A snapshot of the global therapeutic scenario for Equine Encephalitis.- A review of the Equine Encephalitis products under development by companiesand universities/research institutes based on information derived from companyand industry-specific sources.- Coverage of products based on various stages of development ranging fromdiscovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combinedtherapeutics.Table of contents:List of Tables 3List of Figures 4Introduction 5Global Markets Direct Report Coverage 5Equine Encephalitis Overview 6Therapeutics Development 7An Overview of Pipeline Products for Equine Encephalitis 7Equine Encephalitis Therapeutics under Development by Companies 9Equine Encephalitis Therapeutics under Investigation by Universities/Institutes 10Mid Clinical Stage Products 11Comparative Analysis 11Early Clinical Stage Products 12Comparative Analysis 12Pre-Clinical Stage Products 13Comparative Analysis 13Equine Encephalitis Therapeutics – Products under Development by Companies 14Equine Encephalitis Therapeutics – Products under Investigation byUniversities/Institutes 15Companies Involved in Equine Encephalitis Therapeutics Development 16CytoGenix, Inc. 16AlphaVax, Inc. 17Equine Encephalitis – Therapeutics Assessment 18Assessment by Monotherapy Products 18Assessment by Route of Administration 19Assessment by Molecule Type 21Drug Profiles 23DNA Vaccines For Bacterial Infections - Drug Profile 23Product Description 23Mechanism of Action 23R&D Progress 23Equine Encephalitis Vaccine - Drug Profile 24
Product Description 24Mechanism of Action 24R&D Progress 24Western Equine Encephalitis Vaccine - Drug Profile 25List of FiguresList of Tables are also include.For more related Reports Plz follow The link:Pipeline Review, H2 2012http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H22012&PubId=&pagenum=1Nasopharyngeal Cancer – Pipeline Review, H2 2012Medulloblastoma – Pipeline Review, H2 2012Ewing Sarcoma – Pipeline Review, H2 2012Respiratory Syncytial Virus (RSV) Infections – Pipeline Review, H2 2012Equine Encephalitis – Pipeline Review, H2 2012Anaplastic Astrocytoma – Pipeline Review, H2 2012Penile Cancer – Pipeline Review, H2 2012
Natural Killer Cell Lymphomas – Pipeline Review, H2 2012Medullary Thyroid Cancer – Pipeline Review, H2 2012Fever – Pipeline Review, H2 2012Search More Reports Related to This Category :Pharmaceuticals and Healthcarehttp://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals andHealthcare&PubId=&pagenum=1For More details Plz do contact :Aarkstore EnterpriseLavanyaPhone:08149852585Email: firstname.lastname@example.org